Kornitzer Benjamin 4
4 · agilon health, inc. · Filed Mar 9, 2023
Insider Transaction Report
Form 4
Kornitzer Benjamin
Chief Med. & Quality Officer
Transactions
- Exercise/Conversion
Common Stock
2023-03-07$8.99/sh+8,094$72,765→ 18,520 total - Sale
Common Stock
2023-03-07$24.36/sh−8,094$197,197→ 10,426 total - Exercise/Conversion
Common Stock
2023-03-08$8.99/sh+8,094$72,765→ 18,520 total - Sale
Common Stock
2023-03-08$24.44/sh−8,094$197,821→ 10,426 total - Exercise/Conversion
Options (Rights to Buy)
2023-03-07−8,094→ 149,282 totalExercise: $8.99Exp: 2030-01-31→ Common Stock (8,094 underlying) - Exercise/Conversion
Options (Rights to Buy)
2023-03-08−8,094→ 141,188 totalExercise: $8.99Exp: 2030-01-31→ Common Stock (8,094 underlying)
Footnotes (5)
- [F1]Includes restricted stock units.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.26 to $24.465, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.30 to $24.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F5]These options were granted on January 31, 2020 and vested on September 14, 2021.